BamSEC and AlphaSense Join Forces
Learn More

Novelion Therapeutics Inc.

Formerly OTC: NVLNF

Material Contracts Filter

EX-10.4
from 8-K 3 pages Order Authorizing Implementation of (A) Key Executive Incentive Plan, and (B) Key Employee Retention Plan
12/34/56
EX-10.3
from 8-K 118 pages Order: (I) Approving Disclosure Statement; (II) Establishing Date of Confirmation Hearing; (III) Establishing Procedures for Solicitation and Tabulation of Votes to Accept or Reject Plan, Including (A) Approving Form and Manner of Solicitation Packages, (B) Approving Form and Manner of Notice of Confirmation Hearing, (C) Establishing Record Date and Approving Procedures for Distribution of Solicitation Packages, (D) Approving Forms of Ballots, (E) Establishing Deadline for Receipt of Ballots, and (F) Approving Procedures for Vote Tabulations; (IV) Establishing Deadline and Procedures for Filing Objections to Confirmation of Plan; (V) Approving Rights Offering Procedures; and (VI) Granting Related Relief
12/34/56
EX-10.2
from 8-K 148 pages Material contract
12/34/56
EX-10.1
from 8-K 74 pages Material contract
12/34/56
EX-10.3
from 8-K 9 pages Order: (A) Approving and Authorizing Certain Plan Investor Protections; and (B) Granting Related Relief
12/34/56
EX-10.2
from 8-K 4 pages Interim Order (I) Authorizing the Debtors to Continue Operating Under the Terms of the Shared Services Agreements, as Amended, and (II) Granting Related Relief
12/34/56
EX-10.1
from 8-K 79 pages Final Order (I) Authorizing Debtors to Obtain Postpetition Financing Pursuant to Section 364 of the Bankruptcy Code, (II) Authorizing the Use of Cash Collateral Pursuant to Section 363 of the Bankruptcy Code, (III) Granting Adequate Protection to the Prepetition Secured Parties, (IV) Granting Liens and Superpriority Claims, and (V) Modifying the Automatic Stay
12/34/56
EX-10.3
from 8-K 6 pages Amendment to Shared Services Agreements
12/34/56
EX-10.2
from 8-K 80 pages Aegerion Pharmaceuticals, Inc. and Amryt Pharma PLC Plan Funding Agreement May 20, 2019
12/34/56
EX-10.1
from 8-K 438 pages Restructuring Support Agreement
12/34/56
EX-10.2
from 10-Q 11 pages Material contract
12/34/56
EX-10.1
from 10-Q 53 pages Material contract
12/34/56
EX-10.52
from 10-K 7 pages Novelion Therapeutics Inc. Key Executive Incentive Plan
12/34/56
EX-10.40
from 10-K 11 pages Employment Agreement
12/34/56
EX-10.3
from 8-K 23 pages Subordination Agreement
12/34/56
EX-10.2
from 10-Q 2 pages Amendment to Employment Agreement
12/34/56
EX-10.2
from 8-K 2 pages Amendment to Employment Agreement
12/34/56
EX-10.1
from 8-K 8 pages Amendment to Employment Agreement
12/34/56
EX-10.41
from 10-K 6 pages November 30, 2017 by Email Personal and Confidential Greg Perry Re: Resignation Agreement Dear Greg
12/34/56
EX-10.40
from 10-K 6 pages Employment Agreement
12/34/56